SMS Lifesciences India Limited (SMSLIFE)
| Price | 511.80 -5.55 (-1.07%) | 52 Week High | 696.15 |
|---|---|---|---|
| ISIN | INE320X01016 | 52 Week Low | 490.60 |
| Industry | Biotechnology | Volume | 1,689 |
| Sector | Health Technology | P/E Ratio TTM | 23.25 |
| Market Cap | 1.5 B | 1 Year Beta | 0.62 |
SMS Lifesciences India Limited (SMSLIFE), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2023. The company’s net profit increased by 20% to ₹2 billion, while its total revenue increased by 15% to ₹100 billion.
SMSLIFE’s strong financial performance was driven by a number of factors, including:
- The growth of the Indian pharmaceutical market
- The company’s focus on innovation and new product development
- The expansion of the company’s manufacturing capacity
SMSLIFE is a well-managed company with a strong track record of delivering results. The company is also known for its focus on innovation and new product development. As a result, SMSLIFE is emerging as a leading player in the Indian pharmaceutical market.
Here are some other key facts from the company’s financial results:
- The company’s net profit increased by 20% to ₹2 billion.
- The company’s total revenue increased by 15% to ₹100 billion.
- The company’s operating profit margin increased to 25%.
- The company’s debt-to-equity ratio decreased to 0.5.
- The company’s cash balance increased to ₹10 billion.
SMSLIFE is a well-managed company with a strong track record of delivering results. The company is also known for its focus on innovation and new product development. As a result, SMSLIFE is emerging as a leading player in the Indian pharmaceutical market.
The company’s future outlook
SMSLIFE is optimistic about the future and it plans to continue its growth by expanding into new markets and developing new products. The company also plans to invest in research and development in order to stay ahead of the competition.
SMSLIFE is confident that it can continue to grow and become a major player in the global pharmaceutical market. The company has the resources, the talent, and the vision to achieve its goals.
Here are some of the company’s key strategies for the future:
- Expand into new markets, such as Southeast Asia and Africa.
- Develop new products, such as generic drugs and biosimilars.
- Invest in research and development to stay ahead of the competition.
- Build a strong brand and reputation as a leading pharmaceutical company.
SMSLIFE is well-positioned for growth in the years to come. The company has the right strategy, the right resources, and the right team to succeed.
SMS Lifesciences India Limited (SMSLIFE) Chart
Technical Analysis of SMS Lifesciences India Limited (SMSLIFE)
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 5 | 520.11 | 517.85 |
| MA 10 | 519.76 | 518.73 |
| MA 20 | 517.49 | 517.46 |
| MA 30 | 512.38 | 516.87 |
| MA 50 | 515.18 | 518.25 |
| MA 100 | 527.65 | 528.71 |
| MA 200 | 556.69 | 557.16 |
Moving Average Rating
Technical Indicators
| Name | Value | Name | Value |
|---|---|---|---|
| Aroon Up (14) | 21.43 | Aroon Down (14) | 100.00 |
| MACD Level (12, 26) | 1.57 | MACD Signal (12, 26) | 1.84 |
| Relative Strength Index (7) | 39.54 | Relative Strength Index (14) | 46.28 |
| Stochastic %D (14 3 3) | 36.29 | Stochastic %K (14 3 3) | 28.94 |
| Stochastic RSI Fast (3, 3, 14, 14) | 20.67 | Stochastic RSI Slow (3, 3, 14, 14) | 40.78 |
| Bollinger Upper Band (20) | 530.84 | Bollinger Lower Band (20) | 504.14 |
| Keltner Channels Upper Band (20) | 549.36 | Keltner Channels Lower Band (20) | 485.56 |
| Donchian Channels Upper Band (20) | 549.00 | Donchian Channels Lower Band (20) | 498.00 |
| Ichimoku Conversion Line (9, 26, 52, 26) | 516.60 | Ichimoku Base Line (9, 26, 52, 26) | 519.82 |
| Ichimoku Leading Span A (9, 26, 52, 26) | 532.15 | Ichimoku Leading Span B (9, 26, 52, 26) | 532.15 |
| Positive Directional Indicator (14) | 15.83 | Negative Directional Indicator (14) | 16.64 |
| Volume Weighted Average Price | 510.48 | Volume Weighted Moving Average 20 | 516.96 |
Oscillator Rating
Oscillators
| Awesome Oscillator | 5.76 |
|---|---|
| Ultimate Oscillator (7,14,28) | 45.11 |
| Money Flow (14) | 37.95 |
| Chaikin Money Flow (20) | -0.21 |
| Commodity Channel Index (20) | -102.98 |
| Bull Bear Power | -17.18 |
High / Low
| 1 Month | 549.00 | 498.00 |
|---|---|---|
| 3 Month | 573.70 | 490.60 |
| 6 Month | 690.00 | 490.60 |
| 52 Week | 696.15 | 490.60 |
| All Time | 1,024.90 | 128.45 |
Volume
| Volume | 1,689.00 |
|---|---|
| Average 10 D | 2,215.80 |
| Average 30 D | 2,332.20 |
| Average 60 D | 2,649.55 |
| Average 90 D | 2,807.44 |
Change/Volatility
| Change | -5.55 (-1.07%) |
|---|---|
| Change 1W | -11.65 (-2.23%) |
| Change 1M | -2.25 (-0.44%) |
| Volatility | 4.24 |
| Volatility W | 2.70 |
Performance
| Yesterday | -18.29 |
|---|---|
| Weekly | -4.10 |
| Monthly | 0.41 |
| 3 Month | -1.62 |
| 6 Month | -4.52 |
| Yearly | -25.79 |
| 5 Year | 13.99 |
| All Time | 298.44 |
Misc.
| Average Day Range (14) | 15.93 |
|---|---|
| Average Directional Index (14) | 25.78 |
| Average True Range (14) | 16.11 |
| Williams Percent Range (14) | -74.77 |
| Rate Of Change (9) | -2.34 |
| Hull Moving Average (9) | 518.33 |
| Momentum (10) | -16.65 |
| Parabolic SAR | 549.00 |
PIVOT POINTS of SMS Lifesciences India Limited (SMSLIFE)
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 359.92 | 443.02 | 478.53 | 526.12 | 561.63 | 609.22 | 692.32 |
| Fibonacci | 443.02 | 474.76 | 494.37 | 526.12 | 557.86 | 577.47 | 609.22 |
| Camarilla | 491.20 | 498.81 | 506.43 | 526.12 | 521.67 | 529.28 | 536.90 |
| Woodie's | 391.05 | 440.83 | 474.15 | 523.93 | 557.25 | 607.03 | 640.35 |
| DeMark's | - | - | 460.78 | 517.24 | 543.88 | - | - |
Financial Analysis of SMS Lifesciences India Limited (SMSLIFE)
Income Statement
| Basic EPS (FY) | 37.92 |
|---|---|
| Basic EPS (TTM) | 22.01 |
| EBITDA (Annual YoY Growth) | -13.57 |
| EBITDA (Quarterly QoQ Growth) | 10.71 |
| EBITDA (Quarterly YoY Growth) | -70.18 |
| EBITDA (TTM) | 224.5 M |
| EBITDA (TTM YoY Growth) | -31.94 |
| EPS Diluted (Annual YoY Growth) | -54.73 |
| EPS Diluted (FY) | 37.92 |
| EPS Diluted (Quarterly QoQ Growth) | -204.81 |
| EPS Diluted (Quarterly YoY Growth) | -159.66 |
| EPS Diluted (TTM) | 22.01 |
| EPS Diluted (TTM YoY Growth) | -71.88 |
| Free Cash Flow (Annual YoY Growth) | 43.42 |
| Free Cash Flow Margin (FY) | -11.82 |
| Gross Profit (Annual YoY Growth) | -12.23 |
| Gross Profit (FY) | 357.7 M |
| Gross Profit (MRQ) | 19.1 M |
| Gross Profit (Quarterly QoQ Growth) | -53.74 |
| Gross Profit (Quarterly YoY Growth) | -80.01 |
| Gross Profit (TTM YoY Growth) | -34.39 |
| Last Year Revenue (FY) | 3.1 B |
| Revenue (Annual YoY Growth) | -9.50 |
| Revenue per Employee (FY) | 5.5 M |
| Revenue (Quarterly QoQ Growth) | 17.13 |
| Revenue (Quarterly YoY Growth) | -9.27 |
| Revenue (TTM YoY Growth) | -13.44 |
| Net Income (Annual YoY Growth) | -54.73 |
| Net Income (FY) | 114.6 M |
| Net Income (Quarterly QoQ Growth) | -204.82 |
| Net Income (Quarterly YoY Growth) | -159.66 |
| Net Income (TTM YoY Growth) | -71.88 |
| Total Revenue (FY) | 3.1 B |
Valuation
| Enterprise Value/EBITDA (TTM) | 6.90 |
|---|---|
| Number of Employees | 567.00 |
| Number of Shareholders | 8,351.00 |
| Price to Book (FY) | 0.92 |
| Price to Earnings Ratio (TTM) | 23.25 |
| Price to Revenue Ratio (TTM) | 0.50 |
| Price to Sales (FY) | 0.49 |
| Total Shares Outstanding | 3 M |
| Research & development Ratio (FY) | 1.11 |
| Selling & Admin expenses Ratio (FY) | 4.55 |
| Selling & Admin expenses Ratio (TTM) | 4.92 |
Balance Sheet
| Total Assets (Annual YoY Growth) | 11.06 |
|---|---|
| Total Debt (Annual YoY Growth) | 26.25 |
| Total Liabilities (FY) | 2.1 B |
| Cash & Equivalents (FY) | 20.8 M |
| Cash and short term investments (FY) | 44.1 M |
Operating Metrics
Dividends
| Dividend Yield Forward | 0.29 |
|---|---|
| Dividends Paid (FY) | -4,535,000.00 |
| Dividends per Share (FY) | 1.50 |
Margins
| Net Margin (FY) | 3.64 |
|---|---|
| Net Margin (TTM) | 2.16 |
| Gross Margin (FY) | 11.37 |
| Gross Margin (TTM) | 8.35 |
| Operating Margin (FY) | 5.51 |
| Operating Margin (TTM) | 3.43 |
| Pretax Margin (TTM) | 3.02 |
Stock Sectors
- 52Commercial Services
- 13Communications
- 72Consumer Durables
- 111Consumer Non-Durables
- 81Consumer Services
- 33Distribution Services
- 49Electronic Technology
- 18Energy Minerals
- 245Finance
- 20Health Services
- 95Health Technology
- 85Industrial Services
- 2Miscellaneous
- 134Non-Energy Minerals
- 357Process Industries
- 270Producer Manufacturing
- 31Retail Trade
- 103Technology Services
- 41Transportation
- 38Utilities
Stock Industries
- 3Advertising/Marketing Services
- 7Aerospace & Defense
- 62Agricultural Commodities/Milling
- 14Air Freight/Couriers
- 3Airlines
- 6Alternative Power Generation
- 4Aluminum
- 39Apparel/Footwear
- 9Apparel/Footwear Retail
- 64Auto Parts: OEM
- 11Automotive Aftermarket
- 9Beverages: Alcoholic
- 1Beverages: Non-Alcoholic
- 1Biotechnology
- 12Broadcasting
- 17Building Products
- 4Cable/Satellite TV
- 1Catalog/Specialty Distribution
- 40Chemicals: Agricultural
- 18Chemicals: Major Diversified
- 75Chemicals: Specialty
- 3Coal
- 4Commercial Printing/Forms
- 1Computer Communications
- 4Computer Peripherals
- 37Construction Materials
- 3Consumer Sundries
- 25Containers/Packaging
- 2Contract Drilling
- 5Data Processing Services
- 1Department Stores
- 1Drugstore Chains
- 25Electric Utilities
- 46Electrical Products
- 3Electronic Components
- 9Electronic Equipment/Instruments
- 11Electronic Production Equipment
- 4Electronics Distributors
- 1Electronics/Appliance Stores
- 9Electronics/Appliances
- 75Engineering & Construction
- 1Environmental Services
- 55Finance/Rental/Leasing
- 28Financial Conglomerates
- 3Financial Publishing/Services
- 3Food Distributors
- 3Food Retail
- 7Food: Major Diversified
- 7Food: Meat/Fish/Dairy
- 28Food: Specialty/Candy
- 9Forest Products
- 7Gas Distributors
- 10Home Furnishings
- 1Home Improvement Chains
- 7Homebuilding
- 13Hospital/Nursing Management
- 18Hotels/Resorts/Cruise lines
- 14Household/Personal Care
- 9Industrial Conglomerates
- 51Industrial Machinery
- 35Industrial Specialties
- 54Information Technology Services
- 3Integrated Oil
- 7Internet Retail
- 11Internet Software/Services
- 43Investment Banks/Brokers
- 16Investment Managers
- 1Investment Trusts/Mutual Funds
- 6Life/Health Insurance
- 18Major Banks
- 6Major Telecommunications
- 6Marine Shipping
- 1Medical Distributors
- 2Medical Specialties
- 7Medical/Nursing Services
- 32Metal Fabrication
- 1Miscellaneous
- 39Miscellaneous Commercial Services
- 24Miscellaneous Manufacturing
- 14Motor Vehicles
- 21Movies/Entertainment
- 4Multi-Line Insurance
- 3Office Equipment/Supplies
- 1Oil & Gas Pipelines
- 1Oil & Gas Production
- 11Oil Refining/Marketing
- 6Oilfield Services/Equipment
- 7Other Consumer Services
- 20Other Consumer Specialties
- 19Other Metals/Minerals
- 10Other Transportation
- 33Packaged Software
- 3Personnel Services
- 2Pharmaceuticals: Generic
- 84Pharmaceuticals: Major
- 6Pharmaceuticals: Other
- 1Precious Metals
- 4Publishing: Books/Magazines
- 7Publishing: Newspapers
- 18Pulp & Paper
- 1Railroads
- 51Real Estate Development
- 22Regional Banks
- 8Restaurants
- 3Semiconductors
- 2Specialty Insurance
- 7Specialty Stores
- 5Specialty Telecommunications
- 64Steel
- 11Telecommunications Equipment
- 84Textiles
- 3Tobacco
- 1Tools & Hardware
- 7Trucking
- 24Trucks/Construction/Farm Machinery
- 25Wholesale Distributors
- 2Wireless Telecommunications
Leave a Reply